Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis

NCT00141830 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Methotrexate plus ERB-041 for 12 weeks
DRUG: Placebo for 12 weeks

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer